|
|||
|
A Prospective, Multicenter, Open-Label Study of Dose Escalation Therapy in Male Patients With Nocturia Refractory to 0.2-mg Tamsulosin Monotherapy
Ho Song Yu, Jeong Woo Lee, Jihyeong Yu, Min Chul Cho, Sung Yong Cho
Int Neurourol J. 2019;23(4):294-301. Published online 2019 Dec 31
DOI: https://doi.org/10.5213/inj.1938076.038 |
|||
|
Citations to this article as recorded by  Safety and efficacy of tamsulosin 0.4 mg as an initial dose in 1,219 Korean patients with moderate to severe lower urinary tract symptoms: data from a phase IV study
Jun Ho Lee, Yeon Won Park, Moon-hwa Park, Tag Keun Yoo
Prostate International.2023; 11(4): 228. CrossRef Development of a voiding diary using urination recognition technology in mobile environment
Gun Hyun Park, Su Jin Kim, Young Sam Cho
Journal of Exercise Rehabilitation.2020; 16(6): 529. CrossRef
|
